angelicin has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, Y; He, Y; Huang, C; Jin, M; Li, G; Liu, H; Ren, J; Song, X; Xie, S; Yao, J | 1 |
1 other study(ies) available for angelicin and Invasiveness, Neoplasm
Article | Year |
---|---|
Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Cell Movement; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Furocoumarins; Gene Expression; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mice, Nude; Neoplasm Invasiveness; Xenograft Model Antitumor Assays | 2016 |